(HealthDay News) — For patients with cardiomyopathy, use of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) is associated with significantly lower incidence of ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Hospitalized COVID-19 patients with hypertension and on treatment with an renin-angiotensin system ...

Pill removed from blister pack The main outcome of the study was hospital presentation due to serious hypoglycemia. Concomitant use of angiotensin-converting enzyme inhibitors (ACEIs) and insulin ...

ACEIs are routinely recommended for the treatment of hypertension, especially in the presence of left ventricular dysfunction and congestive heart failure. [6–10] ACEIs are also indicated for the ...

—Getting kidney patients to stick with an angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) presents a real challenge. Here are some tips that may help. When it ...

A new study published in the prestigious journal JAMA Cardiology in May 2020 reports that there is no association between the use of ACEIs/ARBs and testing positive for COVID-19. This supports current ...

The side effects of ACEIs and ARBs may be resulting in less frequent use in a population that could benefit from these medications. A new study found that continuous ACEI/ARB use prior to dialysis ...

Blockade of the renin–angiotensin system has beneficial effects in patients with diabetic nephropathy; however, this treatment can induce aldosterone breakthrough and thus become ineffective. New data ...

Three Biomarkers Accurately Detect Kidney Cancer ACE inhibitors and angiotensin-receptor blockers lower the risk for long-term dialysis, death with advanced kidney disease. Use of ACEIs or ARBs is ...

Atezolizumab for locally advanced/metastatic urothelial carcinoma within the compassionate use program in Spain: The IMcompass study. Avelumab first-line (1L) maintenance + best supportive care (BSC) ...